The deal inked by C.R. Bard to settle a raft of product liability lawsuits brought over its pelvic mesh implants is reportedly worth more than $31 million.
The deal between C.R. Bard (NYSE:BCR) and a pair of law firms representing 500 plaintiffs in product liability lawsuits brought over its pelvic mesh implants is reportedly worth $21 million.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1w1r6EZ
Cap comentari:
Publica un comentari a l'entrada